LIAN(Delisted)
LianBioยทNASDAQ
--
--(--)
LIAN Profile
Lianbio
A biotech company that develops therapies to treat cardiovascular, oncology, respiratory, ophthalmology, and inflammatory disease
--
07/17/2019
11/01/2021
NASDAQ Stock Exchange
163
12-31
Depository Receipts (Ordinary Shares)
103 Carnegie Center Drive, Suite 215, Princeton, NJ 08540
--
LianBio was incorporated in the Cayman Islands on July 17, 2019. The company is a global, science-oriented biopharmaceutical company dedicated to the development and commercialization of innovative medicines for patients with unmet medical needs, initially focusing on licensed assets in Greater China and other Asian markets. The company has purposefully designed their organization to successfully execute their vision by identifying, sourcing, developing and commercializing product candidates and partnering with highly innovative biopharmaceutical companies around the world. The company is building an international infrastructure, positioning themselves as partners of choice and providing a platform to provide access to their target markets.
